6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder
Clinical trial NCT01145755 · TERMINATED
Trial details
- NCT number
- NCT01145755
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-11-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.